US Stock MarketDetailed Quotes

AMRX Amneal Pharmaceuticals

Watchlist
  • 8.350
  • +0.100+1.21%
Close Nov 27 16:00 ET
  • 8.300
  • -0.050-0.60%
Post 19:58 ET
2.59BMarket Cap-9823P/E (TTM)

Amneal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
13.29%702.47M
17.15%701.78M
18.23%659.19M
8.20%2.39B
1.18%616.98M
13.65%620.04M
7.10%599.05M
12.04%557.54M
5.67%2.21B
13.57%609.76M
Operating revenue
13.29%702.47M
17.15%701.78M
18.23%659.19M
8.20%2.39B
1.18%616.98M
13.65%620.04M
7.10%599.05M
12.04%557.54M
5.67%2.21B
13.57%609.76M
Cost of revenue
11.72%432.91M
19.21%451.83M
11.01%421.13M
10.19%1.57B
8.31%427.15M
10.30%387.51M
5.63%379.03M
17.42%379.35M
7.77%1.43B
6.44%394.37M
Gross profit
15.92%269.56M
13.60%249.95M
33.60%238.06M
4.57%820.57M
-11.87%189.83M
19.72%232.53M
9.73%220.02M
2.07%178.19M
2.05%784.71M
29.44%215.39M
Operating expense
23.76%193.08M
15.49%167M
9.01%154.83M
0.09%596.32M
6.74%153.66M
3.74%156.02M
-3.08%144.61M
-6.70%142.03M
3.60%595.79M
-4.18%143.96M
Selling and administrative expenses
5.03%118.69M
10.32%116.46M
10.28%112.6M
7.50%429.68M
6.70%109M
12.93%113.01M
6.85%105.57M
3.48%102.1M
9.36%399.7M
5.07%102.16M
Research and development costs
49.23%63.06M
-3.94%37.1M
-0.13%40.28M
-16.13%167.78M
7.62%46.56M
-18.17%42.26M
-25.11%38.62M
-24.70%40.33M
-4.54%200.05M
-18.39%43.27M
Other taxes
1,573.12%11.33M
3,219.51%13.44M
135.84%1.95M
----
----
--677K
--405K
--826K
----
----
Other operating expenses
----
----
----
71.26%-1.14M
--0
105.53%73K
101.11%13K
---1.22M
---3.96M
---1.47M
Operating profit
-0.05%76.48M
9.99%82.95M
130.22%83.24M
18.70%224.25M
-49.36%36.17M
74.56%76.51M
46.95%75.41M
61.81%36.15M
-2.57%188.92M
341.94%71.43M
Net non-operating interest income expense
-28.68%-65.51M
-29.22%-65.72M
-33.23%-65.7M
-58.47%-251.43M
-112.08%-100.35M
-20.09%-50.91M
-42.76%-50.86M
-47.94%-49.32M
-16.39%-158.67M
-39.35%-47.32M
Non-operating interest expense
28.68%65.51M
29.22%65.72M
33.23%65.7M
32.99%210.63M
26.62%59.55M
20.09%50.91M
42.76%50.86M
47.94%49.32M
16.18%158.38M
38.49%47.03M
Total other finance cost
----
----
----
13,922.34%40.81M
----
----
----
----
--291K
----
Other net income (expense)
268.39%4.46M
-37.70%3.18M
-2,591.41%-93.05M
95.30%-13.09M
39.31%-19.28M
-458.81%-2.65M
102.05%5.1M
249.07%3.74M
-961.91%-278.38M
-2,251.90%-31.76M
Gain on sale of security
177.37%2.27M
-162.23%-262K
-162.97%-1.2M
115.99%1.67M
-7.74%2.29M
46.48%-2.94M
107.75%421K
194.44%1.9M
-82.65%-10.45M
144.78%2.48M
Special income (charges)
165.26%1.01M
-121.55%-919K
-3,690.16%-95.93M
93.04%-19.88M
46.21%-20.07M
-396.73%-1.54M
101.71%4.27M
-363.37%-2.53M
-697.72%-285.76M
-9,891.34%-37.31M
-Less：Restructuring and merger&acquisition
-120.61%-858K
103.50%220K
-47.08%1.57M
-545.58%-12.75M
-683.52%-13.6M
617.14%4.16M
-21,562.07%-6.28M
117.36%2.97M
-71.71%2.86M
29.09%2.33M
-Less:Other special charges
94.31%-149K
-65.34%699K
21,741.97%94.36M
-88.47%32.62M
-3.75%33.66M
-1,019.30%-2.62M
-99.19%2.02M
81.26%-436K
1,000.35%282.9M
1,699.95%34.98M
Other non- operating income (expenses)
-35.77%1.18M
945.56%4.36M
-6.71%4.07M
-71.29%5.12M
-148.87%-1.5M
-67.88%1.83M
-93.99%417K
105.70%4.37M
16.33%17.83M
-53.82%3.06M
Income before tax
-32.82%15.42M
-31.20%20.41M
-701.21%-75.52M
83.77%-40.27M
-990.28%-83.46M
953.07%22.96M
112.74%29.66M
4.99%-9.43M
-891.07%-248.13M
53.09%-7.66M
Income tax
276.59%3.67M
15,830.43%3.62M
821.56%6.16M
26.87%8.45M
649.97%9.88M
-145.43%-2.08M
-100.31%-23K
119.30%668K
-40.50%6.66M
-143.41%-1.8M
Net income
-53.03%11.76M
-43.45%16.79M
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
1,147.41%25.03M
112.36%29.68M
-56.25%-10.09M
-1,363.21%-254.79M
71.37%-5.86M
Net income continuous Operations
-53.03%11.76M
-43.45%16.79M
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
1,147.41%25.03M
112.36%29.68M
-56.25%-10.09M
-1,363.21%-254.79M
71.37%-5.86M
Minority interest income
-22.40%11.91M
-39.25%10.79M
416.25%9.97M
128.26%35.27M
447.87%5.31M
5,034.11%15.35M
114.90%17.77M
26.79%-3.15M
-1,407.39%-124.8M
89.17%-1.53M
Net income attributable to the parent company
-101.61%-156K
-49.70%5.99M
-1,219.93%-91.64M
35.38%-83.99M
-2,176.69%-98.65M
460.06%9.68M
109.86%11.92M
-222.03%-6.94M
-1,323.51%-129.99M
32.05%-4.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-101.61%-156K
-49.70%5.99M
-1,219.93%-91.64M
35.38%-83.99M
-2,176.69%-98.65M
460.06%9.68M
109.86%11.92M
-222.03%-6.94M
-1,323.51%-129.99M
32.05%-4.33M
Basic earnings per share
-100.84%-0.0005
-75.00%0.02
-500.00%-0.3
44.19%-0.48
-1,233.33%-0.4
400.00%0.06
110.00%0.08
-400.00%-0.05
-1,328.57%-0.86
25.00%-0.03
Diluted earnings per share
-100.84%-0.0005
-75.00%0.02
-500.00%-0.3
44.19%-0.48
-1,233.33%-0.4
400.00%0.06
110.00%0.08
-400.00%-0.05
-1,328.57%-0.86
25.00%-0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 13.29%702.47M17.15%701.78M18.23%659.19M8.20%2.39B1.18%616.98M13.65%620.04M7.10%599.05M12.04%557.54M5.67%2.21B13.57%609.76M
Operating revenue 13.29%702.47M17.15%701.78M18.23%659.19M8.20%2.39B1.18%616.98M13.65%620.04M7.10%599.05M12.04%557.54M5.67%2.21B13.57%609.76M
Cost of revenue 11.72%432.91M19.21%451.83M11.01%421.13M10.19%1.57B8.31%427.15M10.30%387.51M5.63%379.03M17.42%379.35M7.77%1.43B6.44%394.37M
Gross profit 15.92%269.56M13.60%249.95M33.60%238.06M4.57%820.57M-11.87%189.83M19.72%232.53M9.73%220.02M2.07%178.19M2.05%784.71M29.44%215.39M
Operating expense 23.76%193.08M15.49%167M9.01%154.83M0.09%596.32M6.74%153.66M3.74%156.02M-3.08%144.61M-6.70%142.03M3.60%595.79M-4.18%143.96M
Selling and administrative expenses 5.03%118.69M10.32%116.46M10.28%112.6M7.50%429.68M6.70%109M12.93%113.01M6.85%105.57M3.48%102.1M9.36%399.7M5.07%102.16M
Research and development costs 49.23%63.06M-3.94%37.1M-0.13%40.28M-16.13%167.78M7.62%46.56M-18.17%42.26M-25.11%38.62M-24.70%40.33M-4.54%200.05M-18.39%43.27M
Other taxes 1,573.12%11.33M3,219.51%13.44M135.84%1.95M----------677K--405K--826K--------
Other operating expenses ------------71.26%-1.14M--0105.53%73K101.11%13K---1.22M---3.96M---1.47M
Operating profit -0.05%76.48M9.99%82.95M130.22%83.24M18.70%224.25M-49.36%36.17M74.56%76.51M46.95%75.41M61.81%36.15M-2.57%188.92M341.94%71.43M
Net non-operating interest income expense -28.68%-65.51M-29.22%-65.72M-33.23%-65.7M-58.47%-251.43M-112.08%-100.35M-20.09%-50.91M-42.76%-50.86M-47.94%-49.32M-16.39%-158.67M-39.35%-47.32M
Non-operating interest expense 28.68%65.51M29.22%65.72M33.23%65.7M32.99%210.63M26.62%59.55M20.09%50.91M42.76%50.86M47.94%49.32M16.18%158.38M38.49%47.03M
Total other finance cost ------------13,922.34%40.81M------------------291K----
Other net income (expense) 268.39%4.46M-37.70%3.18M-2,591.41%-93.05M95.30%-13.09M39.31%-19.28M-458.81%-2.65M102.05%5.1M249.07%3.74M-961.91%-278.38M-2,251.90%-31.76M
Gain on sale of security 177.37%2.27M-162.23%-262K-162.97%-1.2M115.99%1.67M-7.74%2.29M46.48%-2.94M107.75%421K194.44%1.9M-82.65%-10.45M144.78%2.48M
Special income (charges) 165.26%1.01M-121.55%-919K-3,690.16%-95.93M93.04%-19.88M46.21%-20.07M-396.73%-1.54M101.71%4.27M-363.37%-2.53M-697.72%-285.76M-9,891.34%-37.31M
-Less：Restructuring and merger&acquisition -120.61%-858K103.50%220K-47.08%1.57M-545.58%-12.75M-683.52%-13.6M617.14%4.16M-21,562.07%-6.28M117.36%2.97M-71.71%2.86M29.09%2.33M
-Less:Other special charges 94.31%-149K-65.34%699K21,741.97%94.36M-88.47%32.62M-3.75%33.66M-1,019.30%-2.62M-99.19%2.02M81.26%-436K1,000.35%282.9M1,699.95%34.98M
Other non- operating income (expenses) -35.77%1.18M945.56%4.36M-6.71%4.07M-71.29%5.12M-148.87%-1.5M-67.88%1.83M-93.99%417K105.70%4.37M16.33%17.83M-53.82%3.06M
Income before tax -32.82%15.42M-31.20%20.41M-701.21%-75.52M83.77%-40.27M-990.28%-83.46M953.07%22.96M112.74%29.66M4.99%-9.43M-891.07%-248.13M53.09%-7.66M
Income tax 276.59%3.67M15,830.43%3.62M821.56%6.16M26.87%8.45M649.97%9.88M-145.43%-2.08M-100.31%-23K119.30%668K-40.50%6.66M-143.41%-1.8M
Net income -53.03%11.76M-43.45%16.79M-709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M1,147.41%25.03M112.36%29.68M-56.25%-10.09M-1,363.21%-254.79M71.37%-5.86M
Net income continuous Operations -53.03%11.76M-43.45%16.79M-709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M1,147.41%25.03M112.36%29.68M-56.25%-10.09M-1,363.21%-254.79M71.37%-5.86M
Minority interest income -22.40%11.91M-39.25%10.79M416.25%9.97M128.26%35.27M447.87%5.31M5,034.11%15.35M114.90%17.77M26.79%-3.15M-1,407.39%-124.8M89.17%-1.53M
Net income attributable to the parent company -101.61%-156K-49.70%5.99M-1,219.93%-91.64M35.38%-83.99M-2,176.69%-98.65M460.06%9.68M109.86%11.92M-222.03%-6.94M-1,323.51%-129.99M32.05%-4.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -101.61%-156K-49.70%5.99M-1,219.93%-91.64M35.38%-83.99M-2,176.69%-98.65M460.06%9.68M109.86%11.92M-222.03%-6.94M-1,323.51%-129.99M32.05%-4.33M
Basic earnings per share -100.84%-0.0005-75.00%0.02-500.00%-0.344.19%-0.48-1,233.33%-0.4400.00%0.06110.00%0.08-400.00%-0.05-1,328.57%-0.8625.00%-0.03
Diluted earnings per share -100.84%-0.0005-75.00%0.02-500.00%-0.344.19%-0.48-1,233.33%-0.4400.00%0.06110.00%0.08-400.00%-0.05-1,328.57%-0.8625.00%-0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data